MENU
KRYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Krystal Biotech (KRYS) Ownership - Who owns Krystal Biotech?

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs... Show more

Profile

Industry
Pharmaceuticals Major
Address
2100 Wharton Street
Phone
+1 412 586-5830
Employees
295
Web
https://www.krystalbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.13B
P/E Ratio
46.01
Total Cash
823.41M
Projected Growth
N/A
Total Debt
9.11M
Revenue
417.3M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
27.93
Total Debt/Equity
N/A
Revenue/Share
13.86 USD as % of share price
View a ticker or compare two or three
KRYS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which provides therapies for rare and orphan diseases

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
2100 Wharton Street
Phone
+1 412 586-5830
Employees
295
Web
https://www.krystalbio.com